PUMA BIOTECHNOLOGY, INC. (PBYI) Revenue 2017–2025
PUMA BIOTECHNOLOGY, INC. (PBYI) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$228.4MFY2025 · since FY2017: $27.7M → $228.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $228.4M | -0.9% |
| FY2024 | $230.5M | -2.2% |
| FY2023 | $235.6M | +3.3% |
| FY2022 | $228.0M | -9.9% |
| FY2021 | $253.2M | +12.5% |
| FY2020 | $225.1M | -17.3% |
| FY2019 | $272.3M | +8.5% |
| FY2018 | $251.0M | +806.6% |
| FY2017 | $27.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice